|
Tzoran I, Papadakis M, Brenner B, Fidalgo Á, Rivas A, Wells PS, Gavín O, Adarraga MD, Moustafa F, Monreal M; Registro Informatizado de Enfermedad TromboEmbólica Investigators. Outcome of Patients with Venous Thromboembolism and Factor V Leiden or Prothrombin 20210 Carrier Mutations During the Course of Anticoagulation. Am J Med. 2017 Apr;130(4):482.e1-482.e9. doi: 10.1016/j.amjmed.2016.11.016. Epub 2016 Dec 14. PubMed PMID: 27986523.
AÑO: 2017; IF: 5.117
|
27986523
|
Martín-Martos F, Trujillo-Santos J, Del Toro J, Bura-Riviere A, Lorenzo A, Barillari G, Soler S, Mahè I, Sahuquillo JC, Monreal M; RIETE Investigators. Gender differences in patients with venous thromboembolism and five common sites of cancer. Thromb Res. 2017 Mar;151 Suppl 1:S16-S20. doi: 10.1016/S0049-3848(17)30061-0. PubMed PMID: 28262228.
AÑO: 2017; IF: 2.779
|
|
Mahé I, Chidiac J, Bertoletti L, Font C, Trujillo-Santos J, Peris M, Pérez Ductor C, Nieto S, Grandone E, Monreal M; RIETE investigators. The Clinical Course of Venous Thromboembolism May Differ According to Cancer Site. Am J Med. 2017 Mar;130(3):337-347. doi: 10.1016/j.amjmed.2016.10.017. Epub 2016 Nov 22. PubMed PMID: 27884650.
AÑO: 2017; IF: 5.117
|
|
Trujillo-Santos J, Di Micco P, Dentali F, Douketis J, Díaz-Peromingo JA, Núñez MJ, Cañas I, Mastroiacovo D, Saraiva de Sousa M, Monreal M; RIETE Investigators. Real-life treatment of venous thromboembolism with direct oral anticoagulants: The influence of recommended dosing and regimens. Thromb Haemost. 2017 Jan 26;117(2):382-389. doi: 10.1160/TH16-07-0494. Epub 2016 Oct 27. PubMed PMID: 27786333.
AÑO: 2017; IF: 4.952
|
|
Trujillo-Santos J, Bergmann JF, Bortoluzzi C, López-Reyes R, Giorgi-Pierfranceschi M, López-Sáez JB, Ferrazzi P, Bascuñana J, Suriñach JM, Monreal M. Once versus twice daily enoxaparin for the initial treatment of acute venous thromboembolism. J Thromb Haemost. 2017 Mar;15(3):429-438. doi: 10.1111/jth.13616. Epub 2017 Feb 18. PubMed PMID: 28120516.
AÑO: 2017
|